Unlocking The Accuracy of HPV Diagnosis | HPV 33 Genotyping PCR Kit

As molecular diagnostics continue to evolve, Bioteke's PR2026-HP04 HPV Genotyping Test Kit has become a benchmark product in the field of HPV testing and genotyping with its superior accuracy, rapidity, and reliability. Designed for professionals in clinical and research fields, the kit provides unparalleled value to hospitals, laboratories, and healthcare providers.

Why HPV Testing Is Important?

Human papillomavirus (HPV) is the leading cause of cervical cancer and other HPV-related diseases. Early detection and accurate high-risk and low-risk HPV genotyping are essential for effective prevention and treatment strategies. Bioteke's PR2026-HP04 is designed with unparalleled accuracy and efficiency to help healthcare professionals make informed decisions.

Key Features of Bioteke PR2026-HP04 HPV Genotyping Test Kit

1. Comprehensive genotyping capabilities.

Detects 18 high-risk HPV genotypes, including HPV16 and HPV18, which are closely associated with cervical cancer.

Covers 15 low-risk genotypes, such as HPV6 and HPV11, which are associated with benign lesions such as genital warts.

2. Advanced Technology.

Uses fluorescent real-time PCR technology to ensure high specificity and sensitivity in detecting viral DNA.

Compatible with most commercial PCR instruments, including ABI 7500, QuantStudio, SLAN-96S, Bio-Rad CFX96 and BTK-96.

3. Excellent Performance.

Lower limit of detection: Can detect HPV DNA as low as 1000 copies/ml.

4. Short detection time.

Provides results within 2 hours, ideal for high-throughput laboratories.

5. Repeatability.

Rigorous testing ensures consistency of results over multiple runs.

6. User-friendly design.

Pre-portioned lyophilized reagents simplify operation and reduce preparation errors.

Includes positive and negative controls to ensure quality and reliability.

7. Regulatory certification.

ISO13485 and CE-IVD certified to meet global quality requirements for diagnostic tools.

Application of Bioteke PR2026-HP04 HPV Genotyping Test Kit

• Cervical cancer screening: can detect high-risk HPV genotypes at an early stage, helping timely intervention.

• Sexual health clinics: provide fast and accurate results for assessing the risk of HPV infection.

• Research laboratories: support epidemiological studies and HPV prevalence studies.

Market attractiveness: Targeting the Global Medical Device Market

The Bioteke PR2026-HP04 HPV genotyping test kit is designed for Southeast Asia, Africa, America, Australia and the Middle East. With the increasing public awareness of cervical cancer prevention and the increasing demand for reliable diagnostic tools, the kit meets the key needs of these regions.

FAQ about Bioteke's PR2026-HP04 HPV Genotyping Test Kit

1. How long can the kit be stored?

The kit is valid for 12 months at -20±5℃.

The pre-packaged freeze-dried system supports room temperature transportation within 30 days.

2. Is this kit suitable for all PCR instruments?

The kit is compatible with mainstream real-time fluorescence PCR platforms, including ABI 7500, QuantStudio, SLAN-96S, Bio-Rad CFX96 and BTK-96.

3. What samples can this kit be used for?

It can be used for vaginal swabs, cervical exfoliated cells, and urine samples.

4. Does this kit require nucleic acid extraction?

It only requires simple extraction and purification of the sample, which greatly simplifies the operation process.

Contact Us for Consulting and Technical Support

Ready to advance your HPV diagnostic capabilities? Contact Bioteke Team for pricing, availability, and more details on the PR2026-HP04 HPV Genotyping Test Kit. 

Let us help you lead the way in accurate and efficient HPV testing.

BIOTEKE CORPORATION

[Website]: www.bioteke.cn

[E-mail]: zr@bioteke.cn 

[Tel/Whatsapp/Wechat]: +86 181-1536-3743

[Address]: No.90 Huiming Rd, Huishan District, Wuxi, Jiangsu Province, China. 214174.